Last reviewed · How we verify

NCT07368920

Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults

Recruiting now NA Last updated 20 March 2026
What this trial tests

NA trial testing Transcutaneous Electrical Nerve Stimulation (TENS) in Low Back Pain in 40 participants. Currently enrolling.

Timeline
1 February 2026
Primary endpoint
1 January 2029
1 January 2029

Quick facts

Lead sponsorXijing Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 February 2026
Primary completion1 January 2029
Estimated completion1 January 2029
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Xijing Hospital

Who can join

Adults 18 to 65, any sex, with Low Back Pain or Paraspinal Muscles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to assess the effects and safety of transcutaneous electrical nerve stimulation (TENS) in adults with myofascial low back pain. Eligible participants will receive TENS treatment 5 times per week for 4 weeks. Pain intensity and functional outcomes will be assessed at baseline and weekly during the 4-week treatment period, and adverse events will be recorded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcutaneous Electrical Nerve Stimulation (TENS)

Trials testing the same drug.

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Xijing Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07368920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing